Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Celgene Corporation

NASDAQ: CELGZHealthcare / Biotechnology / USA
0.9100+0.0600+7.06%Vol 31 9251Y Perf 48.33%
Feb 15th, 2019 15:55
BID0.8900 ASK0.9100
Open0.9500 Previous Close0.8500
Pre-Market- After-Trading-
 - -%  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★★★★ —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)- 
Earnings Rating
Neutral
Price Range Ratio 52wk %
31.50 
Earnings Date
-

Today's Price Range

0.81000.9500

 

52wk Range

0.11002.65

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
33.82%
3 Months
-2.15%
6 Months
-39.33%
1 Year
48.33%
3 Years
-33.58%
5 Years
-68.51%

Quotes

Name / TickerPriceChg.Chg.%
CELGZ0.91000.06007.06
AAPL170.42-0.3800-0.22
GOOG1 113.65-8.0200-0.72
MSFT108.221.32001.23
XOM77.711.44001.89
WFC49.220.70001.44
JNJ136.382.07001.54
FB162.50-1.4500-0.88
GE10.090.05000.50
JPM105.553.13003.06
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
-
Current Ratio
2.10
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
7.50
Leverage Ratio 10.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
96.40
EBIT Margin
37.60
EBITDA Margin
41.60
Pre-tax Profit Margin
27.60
Profit Margin
26.51
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
-
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-
Cash Flow Per Share
-
Price to Tangible Book
-
Book Value per Share
-
Enterprise Value (in ths.)
-
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
39.07
ROE last 12 Months
58.46
Return on Assets (5Y Avg)
7.67
ROA last 12 Months
12.33
Return on Capital (5Y Avg)
-
ROC last 12 Months
13.62
Return on invested Capital Q
-
Return on invested Capital Y
-
Assets Turnover
0.20
Receivables Turnover
4.30
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
15 265 000
Revenue per Share
-
Revenue Growth 3 Years
18.29
Revenue Growth 5 Years
19.36
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume31 925
Shares Outstanding (in ths.)0
Trades Count41
Dollar Volume19 363
Avg. Volume30 141
Avg. Weekly Volume31 580
Avg. Monthly Volume22 160
Avg. Quarterly Volume27 167

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

63%38%

Bearish Bullish

41%59%

Bearish Bullish

59%41%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News